David Shaywitz

1 week ago | aei.org | David Shaywitz |Brian Miller |Sally Satel |Timothy Carney

Op-Ed ‘Super Agers’ Review: Living the Good Life Op-Ed Our Collective Hope for AI in Health, Plus Explanatory Models and an Epic Podcast Article Restraining Health Spending While Protecting Access: Potential For Bipartisan Action Event Health Policy Under the New Administration Op-Ed “What Is It Like to Be an Addict?” Review: The Danger of a Safe Feeling Op-Ed Are the FDA and Drugmakers Covering Up the Abortion Pill’s Risks? Op-Ed Silicon Valley’s Consumer Eugenics Podcast Doctors Are Still...

1 week ago | timmermanreport.com | David Shaywitz |Luke Timmerman

For at least a decade, nearly every tech company has promoted their product as facilitating the “democratization” of something – perhaps “data driven medicine,” or “genetic information” or “access to clinical trials” or “digital health” (all real examples). Like “mission-driven,” “results-oriented,” and “disruptive,” the term “democratization” has become so overused by the tech community that it’s now more of an obligatory buzzword than a meaningful, resonant concept.

1 week ago | timmermanreport.com | David Shaywitz |Luke Timmerman

A recent piece by Nathan Price captures our collective hope for AI in health with unusual clarity, even as there remains impassioned disagreement regarding how close these ambitions are to meaningful realization. For context, Price is Professor and Co-Director of the Center for Human Healthspan at the Buck Institute for Research on Aging and CSO of Thorne, a company best known for its supplements, and which is now expanding into testing.

3 weeks ago | timmermanreport.com | David Shaywitz |Luke Timmerman

(Guest) Editor Note: Martin Gaynor, the Lester A. Hamburg University Professor of Economics and Public Policy at Carnegie Mellon University, was recently honored with the Victor R. Fuchs Award for Lifetime Contributions to the Field of Health Economics by the American Society of Health Economists. His response (shared with his permission) was both striking and magnificent, emphasizing the contingency of his career path, and acknowledging the many different ways things might have turned out.

1 month ago | timmermanreport.com | David Shaywitz |Luke Timmerman

Can you improve your health without obsessing about it? I’ve been, well, obsessing about this question as I continue to spend more time and mindshare in the world of healthy aging evangelists, enthusiasts, and entrepreneurs, longevity champions keen to guide you, and often test you, towards their conceptions of healthier aging. (See this piece on the longevity boom, and this on the role of GLP-1RAs.)Athletes and ConvertsThere seem to be two general flavors of longevity champions.